Poly(A) tail degradation in human cells: ATF4 mRNA as a model for biphasic deadenylation

Area of Science:

• Molecular Biology
• RNA Metabolism
• Gene Regulation

Background:

• Eukaryotic mRNA deadenylation is a crucial gene regulation process.
• It's generally accepted to occur in two distinct phases: initial shortening by PAN2-PAN3 and completion by CCR4-NOT.
• The precise mechanisms, timing, and mRNA specificity of this biphasic model remain unclear.

Purpose of the Study:

• To investigate the biphasic deadenylation mechanism of endogenous mRNAs in human cells.
• To elucidate the roles of the PAN3 complex and translation termination factor eRF3 in mRNA deadenylation.
• To understand the heterogeneity in deadenylation pathways among different mRNAs.

Main Methods:

• Depletion of PAN3 or translation termination factor eRF3 in human cells.
• Analysis of poly(A) tail lengths of endogenous mRNAs, including ATF4.
• Comparative analysis of deadenylation kinetics under different experimental conditions.

Main Results:

• Only endogenous ATF4 mRNA strictly adhered to the proposed two-step biphasic deadenylation model.
• Depletion of eRF3 significantly impacted ATF4 mRNA poly(A) tail shortening, suggesting its role in regulating this process.
• Depletion of PAN3 had a limited effect on the poly(A) tail shortening of most tested mRNAs, questioning the universal applicability of the initial deadenylation step.

Conclusions:

• The biphasic deadenylation model may not apply universally to all eukaryotic mRNAs.
• mRNA-specific differences in the transition timing between deadenylation steps likely exist.
• Alternative or modified deadenylation pathways, potentially involving a rapid transition to the CCR4-NOT complex, may be employed by a subset of mRNAs.